Skip to main content
. 2023 May 29;12(14):15026–15036. doi: 10.1002/cam4.6165

FIGURE 2.

FIGURE 2

(A) Kaplan–Meier curve of locoregional recurrence‐free survival (LRFS) in patients stratified by allele frequency heterogeneity status. (B) Kaplan–Meier curve of LRFS in patients stratified by baseline circulating tumor DNA detection. (C) Univariate and multivariate cox regression analysis of baseline risk factors LRFS.